Lipids, Statins and Heart Failure: An Update

Area of Science:

• Cardiology
• Pharmacology
• Metabolic Diseases

Background:

• Heart failure (HF) involves cardiac dysfunction and structural changes, influenced by neurohormonal systems and cellular interactions.
• Lipid metabolism plays a crucial role in cardiac function and HF development.
• Inflammation, oxidative stress, and endothelial dysfunction contribute to HF progression.

Purpose of the Study:

• To review the complex relationships between lipids, statin therapy, and heart failure.
• To explore the potential benefits of statins in mitigating HF risk factors.
• To assess the current understanding of statins' impact on established heart failure.

Main Methods:

• Narrative review of existing literature.
• Analysis of studies examining lipid metabolism in cardiac function.
• Evaluation of evidence on statin pleiotropic effects and cardiovascular risk factor management.

Main Results:

• Lipid disorders are implicated in the development and progression of heart failure.
• Statins demonstrate potential benefits by influencing lipid metabolism and other cardiovascular risk factors.
• Statin therapy may reduce HF incidence through pleiotropic actions on inflammation, oxidative stress, and neurohormonal systems.
• Statins can improve associated cardiovascular risk factors like metabolic syndrome and chronic kidney disease.

Conclusions:

• Lipid disorders are integral to heart failure pathogenesis.
• Statins show promise in managing lipid disorders and related cardiovascular risks in HF.
• The efficacy of statins in patients with established heart failure remains uncertain and requires further research.
• Specific statin benefits in particular HF patient groups warrant dedicated investigation.